Would proposed 2026 PTC changes alter eligibility or phase-out rules for marketplace subsidies, and how would that impact people near 400% FPL?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Congressional action (or inaction) will determine whether the enhanced Premium Tax Credits (PTCs) that expanded eligibility above 400% of the federal poverty level (FPL) and reduced required household contributions through 2025 remain in effect for 2026; absent an extension the law reverts to pre‑2021 rules, reinstating a 400% FPL cutoff and higher applicable contribution percentages that raise net premiums sharply (CBO/JCT and CRS estimates summarized in Congress/CRS reporting) [1]. Multiple analysts project large premium increases and millions fewer people receiving subsidies in 2026 if enhancements expire—Urban Institute projects 7.3 million fewer subsidized enrollees and 4.8 million more uninsured; KFF and others model big premium spikes for those near and above 400% FPL [2] [3] [4].
1. What the “proposed 2026 PTC changes” actually are: law reversion unless Congress acts
Current federal law schedules the temporary ARPA/IRA enhancements to expire December 31, 2025; if Congress takes no action the PTC formula and eligibility revert to the pre‑2021 structure for plan year 2026, including returning to sliding scale subsidies that stop at 400% of FPL and higher applicable‑percentage caps that increase required household contributions at every income level (Congress/CRS summary and technical appendix) [1]. CMS and other technical materials likewise explain that expanded eligibility above 400% and the lower contribution caps were temporary through 2025 [5].
2. Who near 400% FPL would gain or lose under each path
If the enhancements are extended, people with incomes above 400% FPL could continue to qualify for subsidies when benchmark premiums would otherwise exceed 8.5% of income; if enhancements expire, households above 400% of FPL generally lose eligibility regardless of premium burden, recreating the “subsidy cliff” where crossing 400% FPL means losing all PTCs (healthinsurance.org, CRS/Library of Congress summaries) [6] [7]. Analysts highlight middle‑income examples: KFF and Bipartisan Policy Center modeling show couples or individuals just above 400% (e.g., a 60‑year‑old couple at ~402% FPL) would see annual premiums jump dramatically — tens of thousands of dollars in some scenarios — because they would go from a capped contribution (8.5% under the enhancement) to paying nearly full premium amounts [8] [3].
3. How phase‑out rules and contribution percentages change the math
Under the enhanced PTCs the required contribution percentages were lower and more generous across income bands; reverting in 2026 raises applicable percentages across FPL bands (CRS/CBO discussion and Committee for a Responsible Federal Budget analysis), which raises the household share of premium even for those who remain eligible under 400% FPL [1] [9]. That means two effects if enhancements expire: (a) people below 400% FPL pay more because the subsidy per person shrinks; and (b) people above 400% lose assistance entirely, producing a sharp increase at the cutoff [9] [6].
4. Projected scale: coverage and premium impacts if enhancements expire
Multiple groups model big impacts: Urban Institute projects 7.3 million fewer subsidized marketplace enrollees and 4.8 million more uninsured in 2026 if enhancements end [2]. KFF finds average marketplace premium payments would more than double (114% increase) for enrollees overall, with especially large dollar increases for people at or above 400% FPL—its example: a 60‑year‑old couple at 402% could face a $22,600 annual rise in premium payments in 2026 under their assumptions [3] [4]. CRS and CBO estimate higher gross premiums and coverage losses tied to the expected exit of healthier enrollees, partially amplifying premium increases [1].
5. Operational and regulatory complications that amplify effects
Insurers set 2026 rates assuming whether subsidies will persist; late congressional action may be hard to operationalize before open enrollment because rates, IT displays, and contracts are largely fixed—analysts warn delays reduce the practical benefits of a belated extension (CHIRblog and other analyses) [10]. Separately, other 2026 regulatory changes (e.g., immigrant eligibility rules, special enrollment and verification changes from OBBBA and CMS rules) will further restrict who can actually receive PTCs starting in 2026, disproportionately affecting low‑income lawfully present immigrants and some SEP enrollees (CMS technical guidance and advocacy summaries) [5] [11].
6. Competing perspectives and political choices
Pro‑extension advocates emphasize affordability and coverage gains: extending enhancements keeps premiums lower and sustains the larger marketplace enrollment realized since ARPA (Urban Institute, KFF) [2] [3]. Opponents or fiscal conservatives stress long‑term budget costs—CBO/JCT and budget analysts project sizable net federal spending increases for a permanent extension and debate whether the program is targeted to the intended populations [1] [8]. FactCheck.org and other outlets note dispute over who “benefits most,” with examples showing both middle‑income households above 400% and lower‑income households materially affected by the policy choices [12].
7. What people near 400% FPL should do now (practical context)
Available reporting urges people to update income information, shop marketplaces during open enrollment, and run subsidy calculators because small changes in household income can push someone over the 400% threshold and change eligibility; but sources also warn that if Congress acts late, marketplace displays and insurer rates may not reflect that change in time for practical enrollment decisions (KFF, CBPP, HealthReform guidance) [4] [13] [10].
Limitations: reporting and models differ on exact dollar effects because outcomes depend on local premiums, ages, plan choices, and whether Congress or regulators alter the rules; this note uses only the cited analyses and does not estimate individual household results beyond those published [2] [3] [1].